Methods for comparing drug policies--the utility of composite drug harm indexes.
One of the challenges for drug policy research is being able to compare policy options and outcomes. The development of indexes, such as the UK Drug Harm Index or the UNODC Illicit Drug Index is a way to systematically enable such comparisons. An Index is a single common metric that represents the diverse outcomes or consequences of drug use. An Index may be used for performance monitoring within one country/region over time; to establish societal benefit of drug policies as expressed in social costs saved; to compare countries or regions; or for comparative policy analysis. Clarity of purpose is important in how an Index is used. The consequences or outcomes that can be combined into a single Index include health consequences, crime consequences, public amenity, pain and suffering, labour market outcomes, and drug manufacture and trafficking activity. The choice of outcomes for inclusion is driven by the purpose but also often by practical considerations, such as data availability. The weighting of the consequences is an important consideration in translating the outcomes into a common metric. A monetary unit has a number of advantages: it is a unit that can be measured across diverse impacts; it gives implicit "weighting" of harms; and it is intuitive for policy makers and community. On the other hand, it represents an economic perspective. No one Index will be regarded as suitable and appropriate by every stakeholder and ongoing research effort on Indexes is an important foundational research activity to advance illicit drug policy.
Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2052, Australia. Alison.ritter@unsw.edu.au
Alison
A
Ritter
D003415:Crime / Q000191:economics / Q000517:prevention & control* / Q000706:statistics & numerical data; D004335:Drug and Narcotic Control / Q000191:economics; D033161:Government Regulation; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects* / Q000145:classification / Q000191:economics; D011634:Public Health / Q000191:economics / Q000331:legislation & jurisprudence*; D011640:Public Policy / Q000191:economics; D012107:Research Design; D018570:Risk Assessment; D019966:Substance-Related Disorders / Q000191:economics / Q000453:epidemiology* / Q000517:prevention & control
D013287:Illicit Drugs